Publications

Publications are searchable by topic from the drop-down menu on this page. New resources are added as they are developed. To obtain a hard-copy version of any publication listed here, please contact the centre or unit within NAHO responsible for the publication.

View by topic

The Human Papillomavirus (HPV) is the leading cause of cervical cancer and anogenital warts, and is linked to many other cancers and cytological abnormalities¹. Cervical Cancer is estimated to be the second most common malignant disease affecting women globally².  Indigenous peoples constitute approximately 5% of the world’s population, are disproportionately affected by HPV infections, are at a greater risk for HPV-related genital cancers, are more likely to be diagnosed at a later stage in the disease process, and remain less likely to survive a diagnosis than non-Indigenous peoples³.

In Canada, up to one million people of all ages develop a sexually transmitted infection (STI) every year. First Nations, Inuit and Métis women are more likely than non-Aboriginal women of the same age to become infected with an STI4.

Resources

Human Papillomavirus, or HPV
(fact sheet) 

Human papillomavirus (HPV) is the most common sexually transmitted viral infection in the world today. There are more than 100 different kinds of HPV, and it can infect many parts of the body.

Cervical Cancer and Screening
(fact sheet)

Cancer is a disease where abnormal cells grow without control and can invade other tissues. There are many different types of cancer, which are named after the part of the body where the cancer starts in. Cervical cancer refers to cancer of the cervix.

Presentations

Sources:

  1. PHAC 2007a. National Advisory Committee on Immunization: Statement on Human Papillomavirus Vaccine. CCDR 33(ACS-2): 1-32. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07pdf/acs33-02.pdf,
    and
    World Health Organization. “HPV and Cervical Cancer in the World: 2007 Report”. Vaccine 25.3 (2007): C1-C230. Print.
  2. Health Canada (2006). Screening for Cervical Cancer.  http://www.hc-sc.gc.ca/iyh-vsv/diseases-maladies/cervical-uterus_e.html
  3. a compilation of findings reported via various papers cited in the IPV Indigenous HPV symposium’s annotated bibliography: “HPV Infections, Cervical Cancer and Cervical Cancer Screening Practices in Indigenous Populations”
  4. Audrey Steenbeek, “Empowering Health Promotion: A holistic Approach in Preventing SexuallyTransmitted Infections Among First Nations and Inuit Adolescents in Canada”, 22 (3) Journal of Holistic Nursing, 2004, p. 255.

Human Papillomavirus(HPV) Initiatives:

26th International Papillomavirus Conference: Satellite Symposium
Enhancing HPV Prevention among Indigenous Populations: International Perspectives on Health and Well-Being
Montreal, Quebec
July 5, 2010

This Symposium was presented as part of the International Papillomavirus 2010 Conference. The Symposium was planned and organized by a Planning Committee representing public sector agencies and not for profit organizations. The event was coordinated and hosted by the International Centre for Infectious Diseases. Approximately 100 conference delegates from 19 different countries attended the Symposium, and 80 left contact information in order to continue communications on HPV and Indigenous peoples.

* Symposium Final Report (coming soon)

Objectives: To share current information on the burden of HPV related diseases, to identify promising interventions and wise practices among Indigenous populations internationally.

Opening Comments: Paulette C. Tremblay Ph.D. (Canada)
Chief Executive Officer, National Aboriginal Health Organization

Aboriginal Peoples and HPV Prevention

View more presentations from National Aboriginal Health Organization.

Panel 1: Researching the Burden of HPV Disease, Immunization, and Cervical Screening among Indigenous Populations.

Professor Suzanne Garland (Australia)
Director of Microbiological Research and Head of Clinical Microbiology and Infectious Diseases, Royal Women’s Hospital, Senior Consultant Microbiology, Royal Children’s Hospital; Professor Faculty of Medicine, Dentistry and Health, Department of Obstetrics and Gynaecology, University of Melbourne, Australia

WHINURS HPV GENOTYPE PREVALENCE IN AUSTRALIAN WOMEN PRE-VACCINATION: what differences might there be for indigenous women?

Dr. Isaac Sobol (Canada) MD, CCFP, MHSc
Chief Medical Officer of Health, Dept. of Health and Social Services, Government of Nunavut, Iqaluit, Canada

Burden of HPV Incidence in Nunavut

Panel 2: Primary and Secondary Prevention of HPV Diseases, Cervical and other cancers among Indigenous Populations: Promising Interventions and Wise Practices.

Dr. Eileen F. Dunne (USA) MD, MPH
Medical Epidemiologist Division of Sexually Transmitted Diseases, U.S. Centres for Disease Control

Prevention of HPV Diseases in Indigenous Populations: Examples of promising interventions and activities for Alaska Natives and American Indians

Ms. Telphia Joseph (Australia), BHlthSc
National Indigenous Immunisation Co-ordinator, The National Centre for Immunisation and Surveillance, Kids Research Institute at The Children’s Hospital at Westmead, NSW

Service Providers of HPV vaccination for Aboriginal and Torres Strait Islander Australian Females


Improving HPV Prevention among Aboriginal Peoples Workshop
Winnipeg, Manitoba
December 9, 2008

 

The International Centre for Infectious Disease (ICID) in conjunction with
the Public Health Agency of Canada (PHAC), and supported by The John D. and Catherine T. MacArthur Foundation, hosted a workshop devoted to further understanding the issues with respect to health care to improve HPV disease prevention in Aboriginal communities.

Objectives:
1. To share current information on:

  • Cervical abnormalities, anogenital warts, cancer, and cytology
  • HPV and cervical cancer epidemiology
  • Vaccine developments, accessibility and uptake issues
  • Unique challenges with respect to Aboriginal populations

2. To identify research gaps, research priorities and strategies to move ahead with improved HPV prevention and control among Aboriginal peoples.

3. To identify implementation challenges and strategies for program improvement among Aboriginal communities.

NAHO= National Aboriginal Health Organization, FNC= First Nations Centre, MC= Métis Centre, IT / AC = Inuit Tuttarvingat (formerly known as Ajunnginiq Centre)

NAHO appreciates your opinion. Please take a moment to tell us what you think of the resources you have used.

Click here to send feedback >>